The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania

Author:

Drevinek Pavel12ORCID,Flisiak Robert34ORCID,Nemes Roxana56ORCID,Nogales Crespo Katya A.7ORCID,Tomasiewicz Krzysztof48

Affiliation:

1. Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, 150 06 Prague, Czech Republic

2. Czech Society for Medical Microbiology, Czech Medical Association of J.E. Purkyne, 142 20 Prague, Czech Republic

3. Department of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-540 Białystok, Poland

4. Polish Association of Epidemiologists and Infectiologists, 15-540 Białystok, Poland

5. Department of Preclinical Disciplines, Faculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania

6. Romanian Society of Pneumonology, 050159 Bucharest, Romania

7. Policy Wisdom LLC., Quebradillas 00678-2705, Puerto Rico

8. Department and Clinic of Infectious Diseases and Hepatology SPSK-1, Medical University of Lublin, 20-081 Lublin, Poland

Abstract

This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and particularly in Czech Republic, Poland, and Romania. The paper was constructed based on a review of scientific evidence and national and international policies and recommendations, as well as a process of validation by four experts. The development of new testing technologies, treatment options, and increased awareness of the negative multidimensional impact of ARI profiles transformed differential diagnosis into a tangible and desirable reality. This review covers the following topics: (1) the multidimensional impact of ARIs, (2) ARI rapid diagnostic testing platforms and their value, (3) the policy landscape, (4) challenges and barriers to implementation, and (5) a set of recommendations illustrating a path forward. The findings indicate that rapid diagnostic testing, including at the point of care (POC), can have a positive impact on case management, antimicrobial and antibiotic stewardship, epidemiological surveillance, and decision making. Integrating this strategy will require the commitment of governments and the international and academic communities, especially as we identified room for improvement in the access and expansion of POC rapid testing in the focus countries and the inclusion of rapid testing in relevant policies.

Funder

Abbott Laboratories

Publisher

MDPI AG

Reference223 articles.

1. Our World in Data (2023, December 14). COVID-19 Data Explorer-Total Deaths (per 1M). Our World in Data. Available online: https://ourworldindata.org/explorers/coronavirus-data-explorer?tab=table&zoomToSelection=true&time=2020-03-01..latest&facet=none&country=USA~GBR~CAN~DEU~ITA~IND&pickerSort=asc&pickerMetric=location&Metric=Confirmed+deaths&Interval=Cumulative&Relative+to+Population=true&Color+by+test+positivity=false.

2. Our World in Data (2023, December 14). COVID-19 Data Explorer- Total Cases (per 1M). Our World in Data. Available online: https://ourworldindata.org/explorers/coronavirus-data-explorer?tab=table&zoomToSelection=true&time=2020-03-01..latest&facet=none&country=USA~GBR~CAN~DEU~ITA~IND&pickerSort=asc&pickerMetric=location&Metric=Confirmed+cases&Interval=Cumulative&Relative+to+Population=true&Color+by+test+positivity=false.

3. Our World in Data (2023, December 14). COVID-19 Data Explorer- Share of People with a Complete Initial Protocol. Our World in Data. Available online: https://ourworldindata.org/explorers/coronavirus-data-explorer?tab=table&zoomToSelection=true&time=2020-03-01..2023-07-05&facet=none&country=USA~GBR~CAN~DEU~ITA~IND&pickerSort=asc&pickerMetric=location&Metric=People+fully+vaccinated&Interval=Cumulative&Relative+to+Population=true&Color+by+test+positivity=false.

4. Our World in Data (2023, December 14). COVID-19 Vaccine Boosters Administered per 100 People. Our World in Data. Available online: https://ourworldindata.org/grapher/covid-vaccine-booster-doses-per-capita.

5. World Health Organization Europe (WHO) (2023, September 27). Statement—36 Million People across the European Region May Have Developed Long COVID over the First 3 Years of the Pandemic. WHO. Available online: https://www.who.int/europe/news/item/27-06-2023-statement---36-million-people-across-the-european-region-may-have-developed-long-covid-over-the-first-3-years-of-the-pandemic#:~:text=According%20to%20estimates%20from%20our,3%20years%20of%20the%20pandemic.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3